IBS is an organic GI disease that should be defined by biomarkers

(1) - Department of Medical and Surgical Sciences, ; Bologna/IT

Premium Content

Please purchase any of the premium collections shown to access this library item.


View all of your premium content purchases in myUEG > My Learning.
If you need help or have questions, please contact e-learning@ueg.eu


This item was part of the Diagnosis of IBS: What is the preferred strategy? session at UEG Week 2016

You may be interested in:

Postinfectious Irritable Bowel Syndrome (IBS): Follow-up at 16 year after a single outbreak of Salmonella gastroenteritis
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012
Mast cells: A central role?
English, Presentation, Aetiology / Causes, Irritable Bowel Syndrome, Transmitters / signals / receptors / enteric nervous system, 2009
Mucosal immune biological markers in patients with Irritable Bowel Syndrome (IBS)
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012

Categorisation:

  • Format
    • Presentation
  • Language
    • English
  • UEG Week Pathway
    • Gut Microbiota
    • Immunology
    • Neurogastroenterology & Motility
    • Paediatrics
    • Primary Care
  • Year
    • 2016